Prenatal low-protein and postnatal high-fat diets induce rapid adipose tissue growth by inducing Igf2 expression in Sprague Dawley rat offspring.
Maternal low-protein diets result in lower birth weight followed by accelerated catch-up growth that is accompanied by the development of obesity and glucose intolerance in later life. Whether postnatal high-fat (HF) diets further contribute to the development of obesity and insulin resistance in offspring by affecting adipose tissue metabolism and DNA methylation is currently unknown. Obese-prone Sprague-Dawley rats were fed 8% low protein (LP) or 20% normal protein diets for 3 wk prior to conception and throughout pregnancy and lactation to investigate whether prenatal LP and postnatal HF diets affect the rate of adipose tissue growth, insulin-like growth factor 2 (Igf2) expression, and DNA methylation in male offspring. At weaning, the offspring were fed 10% normal fat or 45% HF diets for 12 wk. The adipose tissue growth rate was increased (up to 26-fold) by the LP prenatal and HF postnatal diets. Adipose tissue Igf2 mRNAs and DNA methylation were increased by the LP prenatal and HF postnatal diets. The LP prenatal and HF postnatal diet increased the number of small adipocytes in adipose tissue and decreased insulin sensitivity. These findings suggest that prenatal LP and postnatal HF intake result in adipose tissue catch-up growth through alterations in the expression of the Igf2 gene and DNA methylation within adipocytes. These alterations in adiposity are accompanied by an increased risk of development of type 2 diabetes.
USDA Agricultural Research Service, Grand Forks Human Nutrition Research Center, Grand Forks, ND.
Kate J
KJ
Claycombe
Eric O
EO
Uthus
James N
JN
Roemmich
Luann K
LK
Johnson
W Thomas
WT
Johnson
D017667:Adipocytes / Q000378:metabolism; D000273:Adipose Tissue / Q000166:cytology / Q000254:growth & development / Q000378:metabolism*; D000818:Animals; D019175:DNA Methylation; D059305:Diet, High-Fat / Q000009:adverse effects*; D018753:Diet, Protein-Restricted / Q000009:adverse effects*; D004041:Dietary Fats / Q000009:adverse effects; D004044:Dietary Proteins / Q000008:administration & dosage; D005260:Female; D007333:Insulin Resistance; D007335:Insulin-Like Growth Factor II / Q000235:genetics / Q000378:metabolism*; D007774:Lactation; D009765:Obesity / Q000209:etiology* / Q000378:metabolism; D011247:Pregnancy; D011297:Prenatal Exposure Delayed Effects; D039401:Prenatal Nutritional Physiological Phenomena; D012333:RNA, Messenger / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D014886:Weaning
D004041:Dietary Fats; D004044:Dietary Proteins; D012333:RNA, Messenger; D007335:Insulin-Like Growth Factor II